Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on Prognostic Biomarkers of Pancreatic Cancer Based on Proteomic Technique

NCT05289895 is registered in ClinicalTrials.gov with The Affiliated Hospital of Qingdao University as lead sponsor.

NCT NCT05289895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05289895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on Prognostic Biomarkers of Pancreatic Cancer Based on Proteomic Technique
Lead sponsor
The Affiliated Hospital of Qingdao University
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2022
Completion date
December 30, 2024
Enrollment
220 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer, prognostic biomarkers, proteomics